Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Li Zhou
Institution:
AstraZeneca (United States)
Observed institution:
AstraZeneca (United States)
ORCID:
0009-0000-6644-9300
Observed ORCID:
0009-0000-6644-9300
OpenAlex ID:
A5102903716
Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy
2022
·
Buyun Chen
, Diansong Zhou
, et al.
·
British Journal of Clinical Pharmacology
·
13
PDF
Pharmacokinetics and safety of transdermal and oral granisetron in healthy Chinese subjects: An open-label, randomized, crossover study
2018
·
Rui Chen
, Xia Chen
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
3
Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers
2023
·
Jiayu Li
, Pei Hu
, et al.
·
Frontiers in Pharmacology
·
1
PDF
Show more works
View as search
Works count:
3
Citation count:
17
H-index:
2
I10-index:
1
Year
Topic
Type